Cited by 329Probiotics and Fermented FoodsCardiac Fibrosis and RemodelingCardiac Ischemia and Reperfusion

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat

Gan, Xiaohong Tracey, Ettinger, Grace, Huang, Cathy X., Burton, Jeremy P., Haist, James V., Rajapurohitam, Venkatesh, Sidaway, James E., Martin, Glynn, Gloor, Gregory B., Swann, Jonathan R., Reid, Gregor, Karmazyn, Morris·2014·Circulation: Heart Failure

DOI 10.1161/circheartfailure.113.000978

Open this paper in CoChat — free account

Abstract

Background—: Probiotics are extensively used to promote gastrointestinal health, and emerging evidence suggests that their beneficial properties can extend beyond the local environment of the gut. Here, we determined whether oral probiotic administration can alter the progression of postinfarction heart failure. Methods and Results—: Rats were subjected to 6 weeks of sustained coronary artery occlusion and administered the probiotic Lactobacillus rhamnosus GR-1 or placebo in the drinking water ad libitum. Culture and 16s rRNA sequencing showed no evidence of GR-1 colonization or a significant shift in the composition of the cecal microbiome. However, animals administered GR-1 exhibited a significant attenuation of left ventricular hypertrophy based on tissue weight assessment and gene expression of atrial natriuretic peptide. Moreover, these animals demonstrated improved hemodynamic parameters reflecting both improved systolic and diastolic left ventricular function. Serial echocardiography revealed significantly improved left ventricular parameters throughout the 6-week follow-up period including a marked preservation of left ventricular ejection fraction and fractional shortening. Beneficial effects of GR-1 were still evident in those animals in which GR-1 was withdrawn at 4 weeks, suggesting persistence of the GR-1 effects after cessation of therapy. Investigation of mechanisms showed a significant increase in the leptin:adiponectin plasma concentration ratio in rats subjected to coronary ligation, which was abrogated by GR-1. Metabonomic analysis showed differences between sham control and coronary artery ligated hearts particularly with respect to preservation of myocardial taurine levels. Conclusions—: The study suggests that probiotics offer promise as a potential therapy for the attenuation of heart failure.

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.113.000978

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T. L., Garrity, G. M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,873
Quantitative and Qualitative β Diversity Measures Lead to Different Insights into Factors That Structure Microbial Communities
Lozupone, C., Hamady, M., Kelley, S. T., & Knight, R. D. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01996-06 · Cited by 2,717
Systemic gut microbial modulation of bile acid metabolism in host tissue compartments
Swann, J. R., Want, E. J., Geier, F. M., Spagou, K., Wilson, I. D., Sidaway, J. E., Nicholson, J. K., & Holmes, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006734107 · Cited by 726
Self-citation
Microbiota restoration: natural and supplemented recovery of human microbial communities
Reid, G., Younes, J. A., van der Mei, H. C., Gloor, G. B., Knight, R. D., & Busscher, H. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2473 · Cited by 607
Self-citation
Adipokines as novel biomarkers and regulators of the metabolic syndrome
Deng, Y., & Scherer, P. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05875.x · Cited by 578
Myocardial Failure in Cats Associated with Low Plasma Taurine: a Reversible Cardiomyopathy
Pion, P. D., Kittleson, M. D., Rogers, Q. R., & Morris, J. G. (1987) · Science · doi:10.1126/science.3616607 · Cited by 500
Microbes and the gut‐brain axis
Bercik, P., Collins, S. M., & Verdu, E. F. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01906.x · Cited by 417
Abdominal contributions to cardiorenal dysfunction in congestive heart failure.
Verbrugge, F. H., Dupont, M., Steels, P., Grieten, L., Malbrain, M., Tang, W. H. W., & Mullens, W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.070 · Cited by 380

Flagged first, then by citations

Show all 38 references

Sorted by citations

Items 101–200 of 326

The critical role of short-chain fatty acids in health and disease: A subtle focus on cardiovascular disease-NLRP3 inflammasome-angiogenesis axis
Juan, Y., Chen, Y., & Xu, M. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109013 · Cited by 47
Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy
Lu, S., Wang, C., Ma, J., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1456030 · Cited by 49
The hidden universe of human milk microbiome: origin, composition, determinants, role, and future perspectives
Consales, A., Cerasani, J., Sorrentino, G., Morniroli, D., Colombo, L., Mosca, F., & Giannì, M. L. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04383-1 · Cited by 50
The Possible Role of Probiotic Supplementation in Inflammation: A Narrative Review
Colletti, A., Pellizzato, M., & Cicero, A. F. G. (2023) · Microorganisms · doi:10.3390/microorganisms11092160 · Cited by 46
Prophylactic Supplementation with Lactobacillus Reuteri or Its Metabolite GABA Protects Against Acute Ischemic Cardiac Injury
Wang, J., Zhang, H., Yuan, H., Chen, S., Yu, Y., Zhang, X., Gao, Z., Du, H., Li, W., Wang, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202307233 · Cited by 43
Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse
Danilo, C., Constantopoulos, E., McKee, L. A. K., Chen, H., Regan, J. A., Lipovka, Y., Lahtinen, S. J., Stenman, L. K., Nguyen, T. V., Doyle, K. P., et al. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0119 · Cited by 44
Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients
Jadoon, A., Mathew, A. V., Byun, J., Gadegbeku, C. A., Gipson, D. S., Afshinnia, F., Pennathur, S., & for the Michigan Kidney Translational Core CPROBE Investigator Group (2018) · American Journal of Nephrology · doi:10.1159/000493862 · Cited by 41
Gut Phageome—An Insight into the Role and Impact of Gut Microbiome and Their Correlation with Mammal Health and Diseases
Zhang, Y., Sharma, S., Tom, L., Liao, Y., & Wu, V. C. H. (2023) · Microorganisms · doi:10.3390/microorganisms11102454 · Cited by 45
Multi-site microbiota alteration is a hallmark of kidney stone formation
Al, K. F., Joris, B. R., Daisley, B. A., Chmiel, J. A., Bjazevic, J., Reid, G., Gloor, G. B., Denstedt, J. D., RAZVI, H. A., & Burton, J. P. (2023) · Microbiome · doi:10.1186/s40168-023-01703-x · Cited by 48
Self-citation
The Effect of Oral Consumption of Probiotics in Prevention of Heart Injury in a Rat Myocardial Infarction Model: a Histopathological, Hemodynamic and Biochemical Evaluation
Sadeghzadeh, J., Vakili, A., Sameni, H. R., Shadnoush, M., Bandegi, A., & Khorasani, M. Z. (2017) · Iranian Biomedical Journal · doi:10.18869/acadpub.ibj.21.3.174 · Cited by 42
Association of serum HMGB2 level with MACE at 1 mo of myocardial infarction: Aggravation of myocardial ischemic injury in rats by HMGB2 via ROS
Liu, Z. H., Dai, D. P., Ding, F., Pan, W. Q., Fang, Y. H., Zhang, Q., Li, M., Yang, P., Wang, X. Q., Shen, Y. H., et al. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00249.2016 · Cited by 42
Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
Belli, M., Barone, L., Longo, S., Prandi, F. R., Lecis, D., Mollace, R., Margonato, D., Muscoli, S., Sergi, D., Federici, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511971 · Cited by 43
Gut microbiota in common elderly diseases affecting activities of daily living
Shimizu, Y. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i42.4750 · Cited by 40
The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications
Ding, K., Song, C., Hu, H.-J., Yin, K., Huang, H., & Tang, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3790721 · Cited by 43
Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation
Shi, B., Li, H., & He, X. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2323237 · Cited by 43
Gut Microbiota Involvement in Ventricular Remodeling Post–Myocardial Infarction
McMillan, A., & Hazen, S. L. (2019) · Circulation · doi:10.1161/circulationaha.118.037384 · Cited by 39
Endocrine organs of cardiovascular diseases: Gut microbiota
Jia, Q., Xie, Y., Lu, C., Zhang, A., Lu, Y., Lv, S., & Zhang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14164 · Cited by 38
Gut Microbiota and Gut–Brain Axis in Hypertension: Implications for Kidney and Cardiovascular Health—A Narrative Review
Młynarska, E., Wasiak, J., Gajewska, A., Bilińska, A., Steć, G., Jasińska, J., Rysz, J., & Franczyk, B. (2024) · Nutrients · doi:10.3390/nu16234079 · Cited by 39
The role of the gut microbiota in the onset and progression of heart failure: insights into epigenetic mechanisms and aging
Matacchione, G., Piacenza, F., Pimpini, L., Rosati, Y., & Marcozzi, S. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01786-9 · Cited by 43
Gut Microbiota and Sex Hormones: Crosstalking Players in Cardiometabolic and Cardiovascular Disease
Maffei, S., Forini, F., Canale, P., Nicolini, G., & Guiducci, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137154 · Cited by 37
High fiber diet attenuate the inflammation and adverse remodeling of myocardial infarction via modulation of gut microbiota and metabolites
Zhao, J., Cheng, W., Lu, H., Shan, A., Zhang, Q., Sun, X., Kang, L., Xie, J., & Xu, B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1046912 · Cited by 36
Gut dysbiosis and metabolic diseases
Bandopadhyay, P., & Ganguly, D. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.031 · Cited by 42
Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis
Cheng, W., Li, S., Lee, T.-I., Lee, T., Chung, C., Kao, Y., & Chen, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9070728 · Cited by 41
Gut Microbiome-Targeted Modulations Regulate Metabolic Profiles and Alleviate Altitude-Related Cardiac Hypertrophy in Rats
Hu, Y., Pan, Z., Huang, Z., Li, Y., Han, N., Zhuang, X., Peng, H., Gao, Q., Wang, Q., Lee, B. J. Y., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01053-21 · Cited by 36
Trimethylamine oxide: a potential target for heart failure therapy
Lv, S., Wang, Y., Zhang, W., & Shang, H. (2021) · Heart · doi:10.1136/heartjnl-2021-320054 · Cited by 35
The Gut in Heart Failure: Current Knowledge and Novel Frontiers
Gallo, A., Macerola, N., Favuzzi, A. M. R., Nicolazzi, M. A., Gasbarrini, A., & Montalto, M. (2022) · Medical Principles and Practice · doi:10.1159/000522284 · Cited by 36
Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis
Yang, L., Wang, T., Zhang, X., Zhang, H., Yan, N., Zhang, G., Yan, R., Li, Y., Yu, J., He, J., et al. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02508-w · Cited by 34
Gut microbiota and myocardial fibrosis
Han, X., Yang, F., & Bao, Z. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175355 · Cited by 35
Simvastatin mitigates increases in risk factors for and the occurrence of cardiac disease following 10 Gy total body irradiation
Lenarczyk, M., Su, J., Haworth, S. T., KOMOROWSKI, R. A., Fish, B. L., Migrino, R. Q., Harmann, L. M., Hopewell, J. W., Kronenberg, A., Patel, S. B., et al. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.145 · Cited by 33
Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischaemic heart disease
Pham, Q. H., Bui, T. V. A., Sim, W., Lim, K. H., Law, C. O. K., Tan, W., Kim, R. Y., Chow, K. T., Park, H., Ban, K., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae128 · Cited by 32
Role of gut microbiota and derived metabolites in cardiovascular diseases
Yu, J., Yang, Y., Chen, W., Hu, J., Jin, Z., Wu, C., & Li, Y. (2025) · iScience · doi:10.1016/j.isci.2025.113247 · Cited by 37
New insights on atherosclerosis: A cross-talk between endocannabinoid systems with gut microbiota
Moludi, J., Alizadeh, M., Yagin, N. L., Pasdar, Y., Nachvak, S. M., Abdollahzad, H., & Tabaei, A. S. (2018) · Journal of Cardiovascular and Thoracic Research · doi:10.15171/jcvtr.2018.21 · Cited by 32
Changes in Gut Microbiome Structure and Function of Rats with Isoproterenol-Induced Heart Failure
Zheng, A., Yi, H., Li, F., Han, L., Yu, J., Cheng, X., Su, H., Hong, K., & Li, J. (2019) · International Heart Journal · doi:10.1536/ihj.18-194 · Cited by 30
The Gut Axis Involvement in Heart Failure
Salzano, A., Cassambai, S., Yazaki, Y., Israr, M. Z., Bernieh, D., Wong, M., & Suzuki, T. (2019) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.08.001 · Cited by 32
The Beneficial Effects of Probiotics via Autophagy: A Systematic Review
Nemati, M., Omrani, G. R., Ebrahimi, B., & Montazeri‐Najafabady, N. (2021) · BioMed Research International · doi:10.1155/2021/2931580 · Cited by 30
Gut macrobiotic and its metabolic pathways modulate cardiovascular disease
Zhu, J., Lyu, J., Zhao, R., Liu, G., & Wang, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1272479 · Cited by 31
The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium
Bermúdez, V., Durán, P., Rojas, E., Diaz, M. P., Rivas, J., Nava, M., Chacín, M., de Bravo, M. C., Carrasquero, R., Ponce, C. C., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.735070 · Cited by 31
Role of Biological Sex in the Cardiovascular-Gut Microbiome Axis
Li, S., & Kararigas, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.759735 · Cited by 29
Gut Microbiota and Coronary Artery Disease: Current Therapeutic Perspectives
Katsimichas, T., Theofilis, P., Tsioufis, K. P., & Tousoulis, D. (2023) · Metabolites · doi:10.3390/metabo13020256 · Cited by 34
Gut Failure: A Review of the Pathophysiology and Therapeutic Potentials in the Gut–Heart Axis
Matsiras, D., Bezati, S., Ventoulis, I., Verras, C., Parissis, J., & Polyzogopoulou, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072567 · Cited by 35
The gut microbiota and cardiovascular disease: Exploring the role of microbial dysbiosis and metabolites in pathogenesis and therapeutics
Mohsenzadeh, A., Pourasgar, S., Mohammadi, A., Nazari, M., Nematollahi, S., Karimi, Y., Firoozbakhsh, P., Mohsenzadeh, H., Kamali, K., & Elahi, R. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123981 · Cited by 33
Understanding connections and roles of gut microbiome in cardiovascular diseases
Rajendiran, E., Ramadass, B., & Ramprasath, V. R. (2020) · Canadian Journal of Microbiology · doi:10.1139/cjm-2020-0043 · Cited by 29
Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction
McKirnan, M. D., Ichikawa, Y., Zhang, Z., Zemljic‐Harpf, A. E., Fan, S., Barupal, D. K., Patel, H. H., Hammond, H. K., & Roth, D. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.01.040 · Cited by 28
The efficacy and safety of probiotics intervention in attenuating cardiac remodeling following myocardial infraction: Literature review and study protocol for a randomized, double-blinded, placebo controlled trial
Moludi, J., Alizadeh, M., Davari, M., Golmohammadi, A., & Maleki, V. (2019) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2019.100364 · Cited by 27
The interplay between probiotics and host autophagy: mechanisms of action and emerging insights
Sadeghloo, Z., Nabavi-Rad, A., Zali, M. R., Klionsky, D. J., & Yadegar, A. (2024) · Autophagy · doi:10.1080/15548627.2024.2403277 · Cited by 26
Association of Small Intestinal Bacterial Overgrowth With Heart Failure and Its Prediction for Short‐Term Outcomes
Song, Y., Liu, Y., Qi, B., Cui, X., Dong, X., Wang, Y., Han, X., Li, F., Shen, D., Zhang, X., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.119.015292 · Cited by 26
Obesity, Cardiovascular and Neurodegenerative Diseases: Potential Common Mechanisms
Kuneš, J., Hojná, S., Mráziková, L., Montezano, A. C. I., Touyz, R. M., & Maletínská, L. (2023) · Physiological Research · doi:10.33549/physiolres.935109 · Cited by 29
Intestinal Flora Dysbiosis Aggravates Cognitive Dysfunction Associated With Neuroinflammation in Heart Failure
Yu, W., Gao, D., Wen, J., WANG, Z., Li, Y., Peng, X., Cong, Y., Li, C., Zhao, A., Liu, S., et al. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.02.002 · Cited by 25
Targeting Gut Microbiota as a Novel Strategy for Prevention and Treatment of Hypertension, Atrial Fibrillation and Heart Failure: Current Knowledge and Future Perspectives
Drapkina, O. M., Yafarova, A. A., Kaburova, A. N., & Kiselev, A. R. (2022) · Biomedicines · doi:10.3390/biomedicines10082019 · Cited by 26
The Interaction of Gut Microbiota and Heart Failure with Preserved Ejection Fraction: From Mechanism to Potential Therapies
Yu, W., Jiang, Y., Xu, H., & Zhou, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11020442 · Cited by 26
Gut microbiota in coronary artery disease: a friend or foe?
Zhang, B., Wang, X., Ran, X., & Li, C. (2020) · Bioscience Reports · doi:10.1042/bsr20200454 · Cited by 25
Probiotic Therapy with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis Results in Infarct Size Limitation in Rats with Obesity and Chemically Induced Colitis
Borshchev, Y. Y., Burovenko, I. Y., Karaseva, A. B., Минасян, С. М., Сергеевич, П. Е., Borshchev, V. Y., Semenova, N. Y., Borshcheva, O. V., Suvorov, A. N., & Galagudza, M. M. (2022) · Microorganisms · doi:10.3390/microorganisms10112293 · Cited by 24
Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome
Drapkina, O. M., & Shirobokikh, O. E. (2018) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2018-14-4-567-574 · Cited by 25
Alarin alleviated cardiac fibrosis via attenuating oxidative stress in heart failure rats
Li, J., Ding, H., Li, Y., Zhou, H., Wang, W., Mei, Y., & Zhang, R. (2021) · Amino Acids · doi:10.1007/s00726-021-03005-8 · Cited by 24
Gut Microbiota in Heart Failure—The Role of Inflammation
Fountoulakis, P. N., Theofilis, P., Vlachakis, P. K., Karakasis, P., Pamporis, K., Sagris, Μ., Dimitroglou, Y., Tsioufis, P., Oikonomou, E. K., Tsioufis, K. P., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13040911 · Cited by 26
Gut Microbiota‐Derived Metabolites Orchestrate Metabolic Reprogramming in Diabetic Cardiomyopathy: Mechanisms and Therapeutic Frontiers
Jin, J., Yang, X., Feng, R., Ye, M.-L., Xu, H., Wang, J., Hu, J., Zuo, H., Lu, J., Song, J., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202501579rr · Cited by 24
Signature‐oriented investigation of the efficacy of multicomponent drugs against heart failure
Wei, J., Guo, F., Zhang, M., Xian, M., Wang, T., Gao, J., Wu, H., Song, L., Zhang, Y., Li, D., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800673rr · Cited by 23
Inhibition of microRNA-146a attenuated heart failure in myocardial infarction rats
He, J., Lu, Y., Song, X., Gong, X., & Li, Y. (2019) · Bioscience Reports · doi:10.1042/bsr20191732 · Cited by 23
Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment
Huang, X., Hu, L., Long, Z., Wang, X., Wu, J., & Cai, J. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2503093 · Cited by 26
Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice
Wang, J., Chen, J., Li, L., Zhang, H., Pang, D., Ouyang, H., Jin, X., & Tang, X. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02524-22 · Cited by 23
Preferential production of G-CSF by a protein-like Lactobacillus rhamnosus GR-1 secretory factor through activating TLR2-dependent signaling events without activation of JNKs
Meshkibaf, S., Fritz, J., Gottschalk, M. G., & Kim, S. O. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0578-2 · Cited by 22
Aging, sex and NLRP3 inflammasome in cardiac ischaemic disease
Alloatti, G., Penna, C. R. R., Comità, S., Tullio, F., Aragno, M., Biasi, F., & Pagliaro, P. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2022.107001 · Cited by 21
Inorganic polyphosphate in cardiac myocytes: from bioenergetics to the permeability transition pore and cell survival
Dedkova, E. N. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150218 · Cited by 21
Lactobacillus delbrueckii subsp. lactis CKDB001 Ameliorates Metabolic Complications in High-Fat Diet-Induced Obese Mice
Jang, H., Joung, H., Chu, J., Cho, M., Kim, Y.-W., Kim, K. H., Shin, C. H., Lee, J., & Ha, J. (2024) · Nutrients · doi:10.3390/nu16244260 · Cited by 19
Dairy associations for the targeted control of opportunistic Candida
Aitzhanova, A., Oleinikova, Y., Mounier, J., Hymery, N., Salas, M. L., Amangeldi, A., Saubenova, M., Alimzhanova, M. B., Ashimuly, K., & САДАНОВ, А. К. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03096-1 · Cited by 21
Probiotics as potential treatments to reduce myocardial remodelling and heart failure via the gut-heart axis: State-of-the-art review
Karmazyn, M., & Gan, X. T. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04683-6 · Cited by 22
Self-citation
Probiotic use in an infectious disease setting
Reid, G. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1300061 · Cited by 22
Self-citation
Gut Microbiota and Heart, Vascular Injury
Zeng, C., & Tan, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_8 · Cited by 19
Gut Microbiota and Cardiovascular System: An Intricate Balance of Health and the Diseased State
Bhat, M. A., Mishra, A. K., Tantray, J. A., Alatawi, H. A., Saeed, M., Rahman, S., & Jan, A. T. (2022) · Life · doi:10.3390/life12121986 · Cited by 21
Human Gut Microbiota in Cardiovascular Disease
Ronen, D., Rokach, Y., Abedat, S., Qadan, A., Daana, S., Amir, O., & Asleh, R. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230012 · Cited by 28
Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue
Wang, J., Zhang, X., Yang, X., Yu, H., Bu, M.-M., Fu, J., Zhang, Z., Xu, H., Hu, J., Lu, J., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1191936 · Cited by 18
The level of serum total bile acid is related to atherosclerotic lesions, prognosis and gut Lactobacillus in acute coronary syndrome patients
Liu, T., Wang, J., Liang, Y., Wu, X.-Y., Li, W., Wang, Y., Jing, A., Liang, M., Sun, L., Dou, J., et al. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2232369 · Cited by 17
Manipulation of the gut microbiota by the use of prebiotic fibre does not override a genetic predisposition to heart failure
Jama, H. A., Fiedler, A., Tsyganov, K., Nelson, E., Horlock, D., Nakai, M. E., Kiriazis, H., Johnson, C. J., Du, X., Mackay, C. R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73614-y · Cited by 17
The Role of Intestinal Flora and Its Metabolites in Heart Failure
Guan, X., & Sun, Z. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s390582 · Cited by 18
Microbiota and Myopericarditis: The New Frontier in the Car-Diological Field to Prevent or Treat Inflammatory Cardiomyo-Pathies in COVID-19 Outbreak
Piccioni, A., Saviano, A., Cicchinelli, S., Franza, L., Rosa, F., Zanza, C., Santoro, M. C., Candelli, M., Covino, M., Nannini, G., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9091234 · Cited by 15
Akkermansia muciniphila participates in the host protection against helminth-induced cardiac fibrosis via TLR2
Wang, J., Liu, X., Sun, R., Mao, H., Liu, M., & Jin, X. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011683 · Cited by 16
Effect of Chitosan oligosaccharides on ischemic symptom and gut microbiota disbalance in mice with hindlimb ischemia
Zhu, L., Hu, B., Guo, Y., Yang, H., Zheng, J., Yao, X., Hu, H., & Liu, H. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116271 · Cited by 16
Interplay Between Gut Microbiota and Amino Acid Metabolism in Heart Failure
Tuerhongjiang, G., Guo, M., Qiao, X., Lou, B., Wang, C., Wu, H., Wu, Y., Yuan, Z., & She, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.752241 · Cited by 19
Lactobacillus reuteri GMNL-263 reduces hyperlipidaemia and the heart failure process in high-calorie diet-fed induced heart dysfunction in rats
Liao, P., Kuo, W., Kuo, C., Yeh, Y., Shen, C.-Y., Chen, Y.-H., Chen, R., Padma, V. V., Chen, Y.-H., & Huang, C. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.11.009 · Cited by 16
Self-citation
Fetal cardiac growth is associated with in utero gut colonization
Guzzardi, M. A., Ait-Alì, L., D’Aurizio, R., Rizzo, F. M., Saggese, P., Sanguinetti, E., Weisz, A., Pellegrini, M., & Iozzo, P. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.10.005 · Cited by 16
Gut-microbiome-based predictive model for ST-elevation myocardial infarction in young male patients
Liu, M., Wang, M., Peng, T., Ma, W., Wang, Q., Niu, X., Hu, L., Qi, B., Guo, D. S., Ren, G., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1031878 · Cited by 14
Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review)
Li, L., Shaowei, X., Chen, Y., Liu, Y., Shen, D., Yu, X., Wu, Z., Sun, Y., Chen, K., Luo, J., et al. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12716 · Cited by 15
Decoding the impact of gut microbiota on heart failure
Zhao, S., Dan, L.-X., Huang, R. S., Shen, Z., Huang, D., Wu, P., & Ma, Z. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101592 · Cited by 16
Human Gut Microbiota in Heart Failure: Trying to Unmask an Emerging Organ
PARASKEVAIDIS, I. A., Xanthopoulos, A. V., Tsougos, E., & Triposkiadis, F. K. (2023) · Biomedicines · doi:10.3390/biomedicines11092574 · Cited by 13
Diet-Induced Microbiome’s Impact on Heart Failure: A Double-Edged Sword
Rodrigues, A. A., Gonçalves, A., Morais, J., Araújo, R., & Falcão‐Pires, I. (2023) · Nutrients · doi:10.3390/nu15051223 · Cited by 13
Unveiling the relationship between gut microbiota and heart failure: Recent understandings and insights
Jain, H., Marsool, M. D. M., Goyal, A., Sulaiman, S. A., Fatima, L., Idrees, M., Sharma, B., Borra, V., Gupta, P., Nadeem, A., et al. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102179 · Cited by 13
Gut–Kidney–Heart: A Novel Trilogy
Caldarelli, M., Franza, L., Rio, P., Gasbarrini, A., Gambassi, G., & Cianci, R. (2023) · Biomedicines · doi:10.3390/biomedicines11113063 · Cited by 14
Lactobacillus levels and prognosis of patients with acute myocardial infarction.
Cai, J., Liu, Y., Wang, J., Wang, J.-X., Wang, Y., Xu, S.-B., Cui, Z., & Gao, J. (2022) · PubMed Central · doi:10.11909/j.issn.1671-5411.2022.02.009 · Cited by 13
Oral and gut microbiome alterations in heart failure: Epidemiology, pathogenesis and response to advanced heart failure therapies
yuzefpolskaya, M., Bohn, B., Ladanyi, A., Khoruts, A., Colombo, P. C., & Demmer, R. T. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.12.009 · Cited by 12
Antibiotic-induced gut dysbiosis: unraveling the gut-heart axis and its impact on cardiovascular health
Kaur, N., Kumar, P., Dhami, M., & Aran, K. R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10425-2 · Cited by 13
Impact of exercise-induced alterations on gut microbiota diversity and composition: comparing effects of different training modalities
Wang, Y., Bai, S., Yang, T., Guo, J.-J., Zhu, X., & Dong, Y. (2025) · Cell Regeneration · doi:10.1186/s13619-025-00244-y · Cited by 14
Dysbiosis—An Etiological Factor for Cardiovascular Diseases and the Therapeutic Benefits of Gut Microflora
Singh, T., Kaur, G., & Kaur, A. (2023) · Advanced Gut & Microbiome Research · doi:10.1155/2023/7451554 · Cited by 16
Lactobacillus rhamnosus GR-1 Attenuates Induction of Hypertrophy in Cardiomyocytes but Not through Secreted Protein MSP-1 (p75)
Ettinger, G., Burton, J. P., Gloor, G. B., & Reid, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168622 · Cited by 12
Self-citation
Heart-gut axis: Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) to prevent cardiovascular disease through gut microbiota
Kv, C. R. (2021) · Medicine in Microecology · doi:10.1016/j.medmic.2021.100033 · Cited by 13
Combined analysis of plasma metabolome and intestinal microbiome sequencing to explore jiashen prescription and its potential role in changing intestine–heart axis and effect on chronic heart failure
Cui, X., Su, Y., Huang, X., Chen, J. P., Ma, J., Liao, P., & He, X. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1147438 · Cited by 11
Effect of probiotic supplementation on in-hospital mortality in patients with acute myocardial infarction: a study protocol for an open-label, randomized, controlled, superiority clinical trial
Chen, Y., Chen, R., Wang, X., Zhou, Y., Hong, L., Xiong, N., Zhu, J., Ye, S., & Tan, X. (2023) · Trials · doi:10.1186/s13063-023-07443-5 · Cited by 11
The Role of Probiotics In Tissue Engineering And Regenerative Medicine
Golchin, A., Ranjbarvan, P., Parviz, S., Shokati, A., Naderi, R., Rasmi, Y., Kiani, S., Moradi, F., Heidari, F., Saltanatpour, Z., et al. (2023) · Regenerative Medicine · doi:10.2217/rme-2022-0209 · Cited by 12
Molecular mechanism of Chuanxiong Rhizoma in treating coronary artery diseases
Yin, B., Guo, Y., Liu, Y., Zhao, Y., Huang, S.-M., Wei, X., Wang, H.-S., Liu, R.-Y., Liu, Y., & Tang, Y. (2021) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2021.03.001 · Cited by 11
Microbial metabolites and heart failure: Friends or enemies?
Lu, X., Liu, J., Zhou, B., Wang, S., Liu, Z., Mei, F., Luo, J., & Cui, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.956516 · Cited by 11
Intraventricular pressure gradient: A novel tool to assess the post-infarction chronic congestive heart failure
El‐Husseiny, H. M., Mady, E. A., Ma, D., Hamabe, L., Takahashi, K., & Tanaka, R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.944171 · Cited by 11

Authors: Gan, X. T., Ettinger, G., Huang, C. X., Burton, J. P., Haist, J. V., Rajapurohitam, V., Sidaway, J. E., Martin, G., Gloor, G. B., Swann, J. R., Reid, G., & Karmazyn, M.
Affiliations: Western University (CA)
ORCID: Burton, Jeremy P.
Sidaway, James E.
Gloor, Gregory B.
Swann, Jonathan R.
Reid, Gregor
Karmazyn, Morris
Venue: Circulation: Heart Failure
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2014-05
Volume: 7
Issue: 3
Pages: 491-499
ISSN: 1941-3289 (ISSN-L)
1941-3297
DOI: 10.1161/circheartfailure.113.000978
OpenAlex: W2154813987
Cited by: 329
References: 38
Citations by year: 2026: 16 · 2025: 31 · 2024: 34 · 2023: 45 · 2022: 46 · 2021: 44 · 2020: 23 · 2019: 21 · 2018: 17 · 2017: 17 · 2016: 12 · 2015: 14 · 2014: 8
FWCI: 24.33
Type: journal article
Language: en
Open access: closed
Locations: Circulation Heart Failure (publishedVersion)
PubMed (publishedVersion)
ePrints Soton (University of Southampton) (submittedVersion)
Funders: World Health Organization
Canadian Institutes of Health Research (MOP62764)
Topics: Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
Keywords: probiotics, Lactobacillus rhamnosus GR-1, myocardial infarction, post-infarction heart failure, left ventricular hypertrophy, atrial natriuretic peptide, leptin/adiponectin ratio, taurine, gut-heart axis, coronary artery occlusion, left ventricular function, cecal microbiota
MeSH terms: Administration, Oral, Animals, Disease Models, Animal, Cardiomegaly, Heart Failure, Heart Ventricles, Hemodynamics, Male, Myocardial Infarction, Rats, Sprague-Dawley, Disease Progression, Probiotics, Rats, Coronary Occlusion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks